Schedule Of Deferred Tax Assets And Valuation Allowance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
December 31,
|
|
|
2020
|
2019
|
|
|
|
|
|
|
Net Operating Loss Carryforwards
|
|
$
|
44,230,000
|
$
|
43,844,000
|
Stock Compensation Expense
|
|
|
551,000
|
|
1,191,000
|
Book Tax Differences on Assets and Liabilities
|
|
|
163,000
|
|
464,000
|
Valuation Allowance
|
|
|
(44,944,000)
|
|
(45,499,000)
|
|
|
|
|
|
|
Net Deferred Tax Assets
|
|
$
|
-
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
December 31,
|
|
|
2019
|
2018
|
|
|
|
|
|
|
Net Operating Loss Carryforwards
|
|
$
|
43,844,000
|
$
|
41,184,000
|
Stock Compensation Expense
|
|
|
1,191,000
|
|
1,608,000
|
Book Tax Differences on Assets and Liabilities
|
|
|
464,000
|
|
195,000
|
Valuation Allowance
|
|
|
(45,499,000)
|
|
(42,987,000)
|
|
|
|
|
|
|
Net Deferred Tax Assets
|
|
$
|
-
|
$
|
-
|
|